Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05345431

Endovascular Denervation for the Treatment of Patients With Peripheral Arterial Disease

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
54 (estimated)
Sponsor
Zhongda Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Sympathetic overactivity partly promotes the development of peripheral artery disease which mainly leads to ischemia of the lower limbs. Endovascular arterial denervation (ED) is a minimally invasive technique which could deliver Radiofrequency energy by a multi-electrode catheter to the Lower limb artery to restore Sympathetic activity. The purpose of this study is to evaluate the effects of multi-electrode radiofrequency ablation system on lower limb ischemia with PAD.

Detailed description

Peripheral arterial disease(PAD) show insufficient blood supply of diseased limbs, which causes intermittent claudication of lower limbs, reduced skin temperature, pain, and chronic progressive disease that still produces ulcer or necrosis. Some clinical studies have shown Sympathetic overactivity in the lower arterial ischemic disease. The multi-electrode radiofrequency ablation system can significantly reduce the excitability of sympathetic nerve, restore the normal response of sympathetic nerve, relieve the pain and discomfort of patients, effectively improve the symptoms of lower limb ischemia, and improve the quality of life of patients.

Conditions

Interventions

TypeNameDescription
DEVICEendovascular denervationTreating with EDN at the site of the iliac artery distal to the superficial femoral artery proximal before balloon dilation or stent implantation
DEVICEPTATreating with balloon dilation or stent implantation

Timeline

Start date
2022-04-25
Primary completion
2025-06-30
Completion
2026-06-30
First posted
2022-04-25
Last updated
2022-04-25

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05345431. Inclusion in this directory is not an endorsement.